ENDOCEUTICS
Live / Registered — Registered (as of 27 Oct 2020)
What this means for you
Registered since 27 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use is due by 27 Oct 2026, and its filing window is open now).
Record
- Serial number
- 77880488
- Registration number
- 6181907
- Mark type
- Word mark
- Filed
- 25 Nov 2009
- Published for opposition
- 10 Mar 2020
- Registered
- 27 Oct 2020
- Next maintenance filing
- §8 declaration of use, due by 27 Oct 2026 (grace period to 27 Apr 2027)
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders; Pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia; Pharmaceutical preparations and substances for the treatment of the endocrine system; Pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; Pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle and mass strength, bone loss
- Class 035 — Advertising and business services: Wholesale distributorship of pharmaceuticals for others
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products to the order and specification of others
- Class 041 — Education and entertainment services: Pharmaceutical educational services and patient educational services, namely, providing classes, workshops and seminars in the field of treatment and prevention of endocrine-related disorders and diseases
- Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals
Owner
- Endoceutics Inc., Quebec City, QUÉBEC, CA
- Endoceutics Inc., Quebec City, QUÉBEC, CA
- Endoceutics Inc., Quebec City, QUÉBEC, CA
Board proceedings on this mark
- Extension of Time to Oppose No. 77880488 — Endo Pharmaceuticals, Inc. v. Endoceutics Inc., filed 17 Mar 2020 (Terminated)
Prosecution history
- 27 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Sept 2020 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 06 May 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 04 May 2020 — ASSIGNED TO PETITION STAFF
- 09 Apr 2020 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 17 Mar 2020 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2020 — PUBLISHED FOR OPPOSITION
- 19 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Feb 2020 — ELECTRONIC RECORD REVIEW COMPLETE
- 03 Feb 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Feb 2020 — EXAMINER'S AMENDMENT ENTERED
- 03 Feb 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 03 Feb 2020 — EXAMINERS AMENDMENT E-MAILED